| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
821-50328103-801 18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:STEARDA;N-[2-(3,4-Dihydroxyphenyl)ethyl]octadecanaMide
CAS:105955-10-0
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
| Company Name: |
Nanjing Chemlin Chemical Co., Ltd
|
| Tel: |
025-83697070 |
| Email: |
info@chemlin.com.cn |
| Products Intro: |
Product Name:N-(3,4-Dihydroxyphenethyl)stearamide
CAS:105955-10-0
Purity:98% Package:100mg; 1g; 10g; 100g; 1kg
|
|
| | N-[2-(3,4-DIHYDROXYPHENYL)ETHYL]OCTADECANAMIDE Basic information |
| | N-[2-(3,4-DIHYDROXYPHENYL)ETHYL]OCTADECANAMIDE Chemical Properties |
| storage temp. | Store at +4°C | | solubility | Soluble to 5 mM in ethanol with gentle warming | | form | Powder |
| | N-[2-(3,4-DIHYDROXYPHENYL)ETHYL]OCTADECANAMIDE Usage And Synthesis |
| Uses | STEARDA is a novel, endogenous capsaicin-like lipid that produces hyperalgesia. | | Definition | ChEBI: N-stearoyl dopamine is a carboxamide. It is functionally related to a dopamine. | | Biological Activity | Endogenous fatty acid dopamide that displays 'entourage' effects on endovanilloids NADA and anandamide. Inactive at TRPV1 and CB 1 receptors (at concentrations up to 5 μ M) and does not inhibit AMT or FAAH (IC 50 > 25 μ M). However, potentiates TRPV1-mediated effects of NADA in vitro and in vivo ; enhances effects on intracellular Ca 2+ (EC 50 lowered 3-fold) and nociception. Also inhibits arachidonate 5-lipoxygenase (IC 50 = 16 nM). |
| | N-[2-(3,4-DIHYDROXYPHENYL)ETHYL]OCTADECANAMIDE Preparation Products And Raw materials |
|